| NCT00001737 | National Eye Institute (NEI) | Eye Disease|Inflammation|Uveitis | 1998-05 | PHASE1 |
| NCT04945096 | The First Affiliated Hospital of Soochow University | Engraft Failure|Relapse|GVHD | 2021-07-01 | PHASE3 |
| NCT04537689 | Singapore General Hospital|Translational Immunology Institute | Plaque Psoriasis | 2020-12-10 | PHASE4 |
| NCT02472054 | Assistance Publique - H?pitaux de Paris|URC-CIC Paris Descartes Necker Cochin | Hemophagocytic Lymphohistiocytosis (HLH) | 2015-06-29 | PHASE1|PHASE2 |
| NCT04239859 | Singapore General Hospital|Translational Immunology Institute | Plaque Psoriasis | 2024-01 | PHASE4 |
| NCT00167583 | University Hospital Tuebingen | Behcet´s Disease|Panuveitis|Posterior Uveitis|Retinal Vasculitis | 2004-11 | PHASE3 |
| NCT02314312 | Mahidol University | Transplantation of Kidney|Expanded Criteria Donor|ECD | 2012-01 | PHASE3 |
| NCT00001212 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Nephrotic Syndrome|Systemic Lupus Erythematosus | 1986-11 | PHASE2 |
| NCT00458250 | Tehran University of Medical Sciences | Leukemia, Myeloid, Acute|Leukemia, Lymphoblastic, Acute | 2006-09 | PHASE1 |
| NCT00223054 | University Hospital Schleswig-Holstein|University of Kiel | Function of Renal Transplant | 2005-03 | |
| NCT02203422 | Shandong University | Immune Thrombocytopenia | 2014-07 | PHASE3 |
| NCT00359658 | Hannover Medical School|Hoffmann-La Roche | Heart Transplantation | 2004-11 | NA |
| NCT03026946 | University Medical Center Groningen|ZonMw: The Netherlands Organisation for Health Research and Development | Hand Eczema | 2017-05-29 | PHASE3 |
| NCT00114777 | Bristol-Myers Squibb | Renal Transplantation | 2005-02 | PHASE3 |
| NCT00001731 | National Eye Institute (NEI) | Keratoconjunctivitis Sicca|Sjogren´s Syndrome | 1997-11 | PHASE2 |
| NCT06802055 | Peking Union Medical College Hospital | Aplastic Anaemia | 2025-01-25 | PHASE2 |
| NCT00303667 | Masonic Cancer Center, University of Minnesota | Acute Myelogenous Leukemia | 2005-01 | PHASE1|PHASE2 |
| NCT04540926 | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | COVID 19 Pneumonia | 2020-09 | PHASE1|PHASE2 |
| NCT06903884 | The University of Hong Kong | Vernal Keratoconjunctivitis | 2026-02-09 | PHASE3 |
| NCT00359814 | Hannover Medical School|Hoffmann-La Roche | Heart Transplantation | 2004-11 | NA |
| NCT00520468 | M.D. Anderson Cancer Center | Myelodysplastic Syndrome | 2004-06 | PHASE2 |
| NCT00956293 | Novartis Pharmaceuticals | Renal Transplantation | 2009-07 | PHASE4 |
| NCT00565669 | Medical University of South Carolina | Dry Eye Syndrome | 2007-10 | NA |
| NCT04376528 | West China Hospital | Hepatitis, Autoimmune|Primary Biliary Cholangitis|Immunosuppression | 2021-06-16 | PHASE4 |
| NCT04688021 | Yi Luo | Leukemia|Graft-versus-host-disease | 2020-12-03 | PHASE2 |
| NCT06766357 | Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Moderate to Severe Dry Eye | 2025-04-03 | PHASE3 |
| NCT02276001 | Kowa Research Institute, Inc. | Healthy | 2014-06 | PHASE1 |
| NCT01626092 | Masonic Cancer Center, University of Minnesota | Lysosomal Storage Disease|Peroxisomal Disorder | 2012-07-11 | NA |
| NCT01093586 | Case Comprehensive Cancer Center | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Erythroleukemia (M6a)|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Adult Pure Erythroid Leukemia (M6b)|B-cell Adult Acute Lymphoblastic Leukemia|B-cell Childhood Acute Lymphoblastic Leukemia|Blastic Phase Chronic Myelogenous Leukemia|Burkitt Lymphoma|Childhood Acute Erythroleukemia (M6)|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Megakaryocytic Leukemia (M7)|Childhood Acute Minimally Differentiated Myeloid Leukemia (M0)|Childhood Acute Monoblastic Leukemia (M5a)|Childhood Acute Monocytic Leukemia (M5b)|Childhood Acute Myeloid Leukemia in Remission|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Cutaneous B-cell Non-Hodgkin Lymphoma|de Novo Myelodysplastic Syndromes|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Juvenile Myelomonocytic Leukemia|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Previously Treated Myelodysplastic Syndromes|Prolymphocytic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Relapsing Chronic Myelogenous Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Secondary Myelofibrosis|Splenic Marginal Zone Lymphoma|Stage I Chronic Lymphocytic Leukemia|Stage II Chronic Lymphocytic Leukemia|Stage III Chronic Lymphocytic Leukemia|Stage IV Chronic Lymphocytic Leukemia|T-cell Adult Acute Lymphoblastic Leukemia|T-cell Childhood Acute Lymphoblastic Leukemia|T-cell Large Granular Lymphocyte Leukemia|Waldenstrom Macroglobulinemia | 2007-09 | PHASE2 |
| NCT04812951 | Campus Bio-Medico University | Ocular Surface Disease|Ocular Inflammation | 2021-02-17 | EARLY_PHASE1 |
| NCT06790095 | University of California, San Francisco|U.S. Army Medical Research and Development Command | Traumatic Brain Injury | 2026-02 | PHASE2 |
| NCT01109498 | Amsterdam Molecular Therapeutics|International Antiviral Therapy Evaluation Center | Familial Lipoprotein Lipase Deficiency | 2007-08 | PHASE2|PHASE3 |
| NCT07196449 | Seoul National University Bundang Hospital | Drug Drug Interaction (DDI) | 2025-05-14 | PHASE1 |
| NCT01901471 | Hospices Civils de Lyon | Acute Myocardial Infarction | 2015-09 | PHASE2 |
| NCT00723099 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Aggressive Non-Hodgkin Lymphoma|Chronic Myelogenous Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Indolent Non-Hodgkin Lymphoma|Lymphoma|Mixed Phenotype Acute Leukemia|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Recurrent Chronic Lymphocytic Leukemia|Recurrent Follicular Lymphoma|Recurrent Lymphoplasmacytic Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Recurrent T-Cell Non-Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia|Refractory Follicular Lymphoma|Refractory Hodgkin Lymphoma|Refractory Lymphoplasmacytic Lymphoma|Refractory Mantle Cell Lymphoma|Refractory Small Lymphocytic Lymphoma|T-Cell Non-Hodgkin Lymphoma | 2008-06-25 | PHASE2 |
| NCT06876116 | Korea University Anam Hospital|Taejoon Pharmaceutical Co., Ltd. | Dry Eye Disease (DED) | 2022-09-01 | PHASE4 |
| NCT00005866 | SWOG Cancer Research Network|National Cancer Institute (NCI) | Leukemia|Myelodysplastic Syndromes | 2000-02 | PHASE3 |
| NCT05946772 | University Hospital Heidelberg|German Centre of Cardiovascular Research (DZHK)|Coordinating Centre for Clinical Studies (KKS) Heidelberg | Takotsubo Cardiomyopathy | 2025-02-01 | PHASE2 |
| NCT02936505 | Vastra Gotaland Region|Oslo University Hospital|Helsinki University Central Hospital|Skane University Hospital|Copenhagen University Hospital, Denmark | Lung Transplantation|Allografts | 2016-10-12 | NA |
| NCT00003950 | University of Chicago|National Cancer Institute (NCI) | Colorectal Cancer | 2000-01 | PHASE2 |
| NCT01149759 | Rockefeller University | Atopic Dermatitis|Eczema | 2010-06 | NA |
| NCT00387959 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Leukemia|Lymphoma | 2006-07 | PHASE2 |
| NCT06658002 | University of California, San Francisco|Aravind Eye Hospitals, India|Aravind Eye Care System | Fungal Keratitis|Corneal Ulcer | 2025-09-01 | PHASE3 |
| NCT04515329 | Vishal Jhanji|Sun Pharmaceutical Industries Limited | Dry Eye | 2023-12-08 | PHASE4 |
| NCT03710044 | LEO Pharma | Atopic Dermatitis | 2019-01-14 | PHASE4 |
| NCT00286624 | University of Minnesota|Juvenile Diabetes Research Foundation|National Institutes of Health (NIH)|Novartis | Type 1 Diabetes Mellitus|Hypoglycemia | 2003-03 | PHASE1|PHASE2 |
| NCT01504906 | AstraZeneca | Healthy | 2012-01 | PHASE1 |
| NCT00944749 | National Heart, Lung, and Blood Institute (NHLBI) | Anemia, Aplastic|Anemia, Hypoplastic | 2009-08-31 | PHASE2 |
| NCT02865356 | Spherium Biomed|Germans Trias i Pujol Hospital|Hospital del Mar|Hospital Sant Joan de Deu|Hospital Universitario Virgen Macarena|Hospital Universitario La Fe|Hospital General Universitario de Alicante|Fundación de Investigación Biomédica - Hospital Universitario de La Princesa|Hospital Universitario Virgen de la Victoria|Hospital Infantil Universitario Ni?o Jesús, Madrid, Spain | Atopic Dermatitis | 2016-09 | PHASE2 |
| NCT00001964 | National Heart, Lung, and Blood Institute (NHLBI) | Severe Aplastic Anemia | 2000-03-17 | PHASE2 |
| NCT00309842 | Masonic Cancer Center, University of Minnesota | Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Myelofibrosis|MDS|Refractory Anemia|Chronic Lymphocytic Leukemia|Prolymphocytic Leukemia|Non-Hodgkin´s Lymphoma|Leukemia|Lymphoma|Multiple Myeloma|Myelodysplastic Syndromes | 2005-07-28 | PHASE2 |
| NCT00002456 | Fred Hutchinson Cancer Center | Graft Versus Host Disease|Leukemia|Lymphoma | 1986-05 | PHASE3 |
| NCT01624805 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Aplastic Anemia|de Novo Myelodysplastic Syndrome|Myelodysplastic Syndrome|Previously Treated Myelodysplastic Syndrome | 2012-06-25 | PHASE2 |
| NCT04392531 | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | COVID19 Infection | 2020-04-16 | PHASE4 |
| NCT00350545 | Stanford University | Graft vs Host Disease | 2006-08 | NA |
| NCT00005937 | Neal Young, M.D. | Myelodysplastic Syndrome | 2000-06 | PHASE2 |
| NCT04488081 | QuantumLeap Healthcare Collaborative|University of California, San Francisco|Emory University|University of Alabama at Birmingham|University of Colorado, Denver|University of Southern California|Yale University|Wake Forest University Health Sciences|Long Beach Memorial Medical Center|Georgetown University|University of California, Davis|Main Line Health|DHR Health Institute for Research and Development|University of California, Irvine|University of Michigan|West Virginia University|University of Miami|University Hospitals Cleveland Medical Center|M.D. Anderson Cancer Center | COVID-19 | 2020-07-31 | PHASE2 |
| NCT05867329 | Berinstein, Jeffrey|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Ulcerative Colitis Acute | 2023-09-30 | PHASE4 |
| NCT00987207 | Hospices Civils de Lyon | Aortic Valvular Surgery | 2008-10 | PHASE3 |
| NCT00884585 | Allergan | Atopic Conjunctivitis | 2009-05 | PHASE3 |
| NCT00741338 | Genzyme, a Sanofi Company|BioMarin+Genzyme LLC | Mucopolysaccharidosis I | 2008-09 | PHASE1|PHASE2 |
| NCT00006055 | Fairview University Medical Center | Purpura, Schoenlein-Henoch|Graft Versus Host Disease|Anemia, Hemolytic, Autoimmune|Rheumatoid Arthritis|Churg-Strauss Syndrome|Hypersensitivity Vasculitis|Wegener´s Granulomatosis|Systemic Lupus Erythematosus|Giant Cell Arteritis|Pure Red Cell Aplasia|Juvenile Rheumatoid Arthritis|Polyarteritis Nodosa|Autoimmune Thrombocytopenic Purpura|Takayasu Arteritis | 2000-03 | NA |
| NCT01938625 | Janssen R&D Ireland | Hepatitis C, Chronic | 2013-12-12 | PHASE2 |
| NCT00078858 | Fred Hutchinson Cancer Center|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Grade III Lymphomatoid Granulomatosis|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Grade III Lymphomatoid Granulomatosis|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Childhood Renal Cell Carcinoma|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Clear Cell Renal Cell Carcinoma|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage II Grade 3 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|de Novo Myelodysplastic Syndromes|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Juvenile Myelomonocytic Leukemia|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Burkitt Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Grade 3 Follicular Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Post-transplant Lymphoproliferative Disorder|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Renal Cell Cancer|Recurrent Small Lymphocytic Lymphoma|Recurrent+Refractory Childhood Hodgkin Lymphoma|Refractory Anemia|Refractory Anemia With Ringed Sideroblasts|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Relapsing Chronic Myelogenous Leukemia|Splenic Marginal Zone Lymphoma|Stage I Adult Burkitt Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Mixed Cell Lymphoma|Stage I Adult Immunoblastic Large Cell Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage I Adult T-cell Leukemia+Lymphoma|Stage I Childhood Anaplastic Large Cell Lymphoma|Stage I Childhood Large Cell Lymphoma|Stage I Childhood Lymphoblastic Lymphoma|Stage I Childhood Small Noncleaved Cell Lymphoma|Stage I Grade 3 Follicular Lymphoma|Stage I Mantle Cell Lymphoma|Stage II Adult T-cell Leukemia+Lymphoma|Stage II Childhood Anaplastic Large Cell Lymphoma|Stage II Childhood Large Cell Lymphoma|Stage II Childhood Lymphoblastic Lymphoma|Stage II Childhood Small Noncleaved Cell Lymphoma|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Adult T-cell Leukemia+Lymphoma|Stage III Childhood Anaplastic Large Cell Lymphoma|Stage III Childhood Large Cell Lymphoma|Stage III Childhood Lymphoblastic Lymphoma|Stage III Childhood Small Noncleaved Cell Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-cell Leukemia+Lymphoma|Stage IV Childhood Anaplastic Large Cell Lymphoma|Stage IV Childhood Large Cell Lymphoma|Stage IV Childhood Lymphoblastic Lymphoma|Stage IV Childhood Small Noncleaved Cell Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Renal Cell Cancer|T-cell Large Granular Lymphocyte Leukemia|Type 1 Papillary Renal Cell Carcinoma|Type 2 Papillary Renal Cell Carcinoma|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Adult Acute Myeloid Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies|Waldenstr?m Macroglobulinemia | 2003-09 | PHASE1|PHASE2 |
| NCT05109390 | Alexion Pharmaceuticals, Inc.|Achillion, a wholly owned subsidiary of Alexion | Healthy | 2018-07-27 | PHASE1 |
| NCT00553202 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 2008-01 | PHASE2 |
| NCT06329661 | Novaliq GmbH | Dry Eye Disease | 2024-04-22 | PHASE4 |
| NCT01043640 | Masonic Cancer Center, University of Minnesota | Mucopolysaccharidosis|Hurler Syndrome|Hunter Syndrome|Maroteaux-Lamy Syndrome|Sly Syndrome|Alpha Mannosidosis|Fucosidosis|Aspartylglucosaminuria|Adrenoleukodystrophy (ALD)|Krabbe Disease|Metachromatic Leukodystrophy (MLD)|Sphingolipidoses|Peroxisomal Disorders | 2009-12 | PHASE2 |
| NCT00213590 | University Hospital, Rouen | Kidney Transplantation|Primary Prevention|Kidney Failure | 2000-04 | PHASE3 |
| NCT03419910 | Bristol-Myers Squibb | Psoriasis | 2018-03-05 | PHASE1 |
| NCT06809608 | Hoffmann-La Roche | Healthy Participants | 2025-02-13 | PHASE1 |
| NCT00003625 | Children´s Oncology Group|National Cancer Institute (NCI) | Brain Tumors|Central Nervous System Tumors | 1998-12 | PHASE1 |
| NCT04692376 | Nanfang Hospital, Southern Medical University|Sun Yat-sen University|Army Medical University, China|Peking University People´s Hospital | Chronic Graft-versus-host Disease | 2021-01-10 | PHASE2 |
| NCT04775303 | Yonsei University | Moderate to Severe Dry Eye | 2020-09-25 | PHASE4 |
| NCT00317785 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia|Lymphoma|Myelodysplastic Syndromes | 2005-05 | PHASE2 |
| NCT00988715 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Chronic Myelomonocytic Leukemia|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Previously Treated Myelodysplastic Syndrome|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Refractory Anemia With Excess Blasts|Refractory Cytopenia With Multilineage Dysplasia|Refractory Cytopenia With Multilineage Dysplasia and Ringed Sideroblasts|Secondary Acute Myeloid Leukemia | 2010-04-21 | PHASE1 |
| NCT00005854 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 1999-12 | PHASE2 |
| NCT05294666 | Peking University Third Hospital | Graft Versus Host Disease in Eye | 2020-04-01 | PHASE4 |
| NCT00035555 | Bristol-Myers Squibb | Graft Rejection|Kidney Transplantation|Renal Transplantation | 2001-03 | PHASE2 |
| NCT01109056 | Allergan | Pterygium | 2010-06 | PHASE2 |
| NCT00755781 | APT Pharmaceuticals, Inc. | Lung Transplant | 2008-09 | PHASE3 |
| NCT00185692 | Stanford University | Blood Cancer|Leukemia|Graft Versus Host Disease|Malignancy|CLL|NHL|Hodgkin´s Disease|MDS | 2000-08 | PHASE2 |
| NCT01706692 | Swiss Dermatology Network for Targeted Therapies | Psoriasis | 2011-02 | |
| NCT00502073 | Sirion Therapeutics, Inc. | Dry Eye Syndromes | | PHASE3 |
| NCT00003270 | Roswell Park Cancer Institute | Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 1997-09-04 | PHASE2 |
| NCT00544115 | City of Hope Medical Center|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases|Precancerous+Nonmalignant Condition | 2001-10-16 | PHASE2 |
| NCT00438360 | Novartis Pharmaceuticals | Chronic Plaque Psoriasis | 2006-05 | PHASE3 |
| NCT01080586 | Panacea Biotec Ltd | Healthy Volunteers | 2007-09 | NA |
| NCT00609739 | Masonic Cancer Center, University of Minnesota | Leukemia | 1999-06 | PHASE1|PHASE2 |
| NCT06512766 | Erasmus Medical Center | Cicatricial Alopecia|Lichen Planopilaris|Lichen Plano-Pilaris|Frontal Fibrosing Alopecia|Hair Diseases|Scarring Alopecia|Hair Loss+Baldness | 2022-09-23 | |
| NCT00003056 | Baxalta now part of Shire | Leukemia|Lymphoma|Graft Versus Host Disease | 1997-04-01 | PHASE3 |
| NCT05202145 | Alexion Pharmaceuticals, Inc. | Healthy | 2022-01-11 | PHASE1 |
| NCT00332462 | Novartis Pharmaceuticals | Liver Transplantation | 2006-05 | PHASE4 |
| NCT00903188 | University Hospital, Antwerp|Novartis Pharmaceuticals|Erasme University Hospital|University Hospital, Ghent|University of Liege|Universitair Ziekenhuis Brussel | Renal Transplantation | 2008-10 | PHASE4 |
| NCT00118742 | Hoffmann-La Roche | Liver Transplantation | 2005-08 | PHASE4 |
| NCT00195624 | National Heart, Lung, and Blood Institute (NHLBI) | Severe Aplastic Anemia, Refractory|Severe Aplastic Anemia, Relapse | 2005-09-15 | PHASE2 |
| NCT00452361 | Wyeth is now a wholly owned subsidiary of Pfizer | Kidney Transplantation | 2007-04 | PHASE4 |
| NCT01497483 | University of California, San Francisco|National Institute of General Medical Sciences (NIGMS) | Healthy | 2011-12 | PHASE1 |
| NCT04127851 | Taejoon Pharmaceutical Co., Ltd. | Dry Eye|Dry Eye Syndromes | 2019-11-12 | PHASE4 |
| NCT00001965 | National Heart, Lung, and Blood Institute (NHLBI) | Cardiomyopathy, Hypertrophic|Heart Hypertrophy | 1999-12 | PHASE2 |
| NCT00686556 | Masonic Cancer Center, University of Minnesota | Acute Lymphoblastic Leukemia|Myelodysplastic Syndrome|Multiple Myeloma | 2012-08 | PHASE1 |
| NCT01768312 | Hanlim Pharm. Co., Ltd. | Dry Eye Syndromes | 2012-08-23 | PHASE3 |
| NCT02617667 | Novaliq GmbH | Dry Eye Syndromes | 2016-01 | PHASE2 |
| NCT00023244 | National Institute of Allergy and Infectious Diseases (NIAID)|Cooperative Clinical Trials in Pediatric Transplantation | End-Stage Renal Disease | 2001-01 | PHASE2 |
| NCT00003145 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Accelerated Phase of Disease|Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Phase of Disease|Recurrent Disease | 1997-08 | PHASE2 |
| NCT00777933 | Samsung Medical Center | Kidney Transplantation|Living Donors | 2000-07 | NA |
| NCT02887807 | Hospices Civils de Lyon | Shockable Out of Hospital Cardiac Arrest | 2017-01 | PHASE3 |
| NCT00007787 | National Institute of Allergy and Infectious Diseases (NIAID) | Kidney Transplantation|Chronic Allograft Nephropathy | 2000-04 | NA |
| NCT00006233 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Melanoma (Skin) | 2000-01 | PHASE2 |
| NCT00000880 | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections | | PHASE2 |
| NCT04492891 | Bryan Burt, MD|Brigham and Women´s Hospital | SARS (Disease) | 2020-11-23 | PHASE2 |
| NCT04532918 | AstraZeneca|Parexel | Chronic Kidney Disease | 2020-09-10 | PHASE1 |
| NCT00154310 | Novartis | Renal Transplantation | 2005-06 | PHASE4 |
| NCT00001533 | National Heart, Lung, and Blood Institute (NHLBI) | Anemia|Leukemia, T-Cell|Lymphocytosis|Neutropenia|Thrombocytopenia | 1996-09 | PHASE1 |
| NCT00089050 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia | 2004-05 | PHASE2 |
| NCT00002785 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 1996-07 | PHASE2 |
| NCT00008450 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI)|National Heart, Lung, and Blood Institute (NHLBI) | Adenosine Deaminase Deficiency|Autosomal Recessive Disorder|Immune System Disorder|Purine-Nucleoside Phosphorylase Deficiency|Severe Combined Immunodeficiency|Severe Combined Immunodeficiency With Absence of T and B Cells|X-Linked Severe Combined Immunodeficiency | 1997-08-11 | PHASE1 |
| NCT04895423 | National Medical Research Center for Children´s Health, Russian Federation | Atopic Dermatitis | 2021-11-25 | PHASE4 |
| NCT00070174 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 2003-12 | PHASE2 |
| NCT02707393 | St. Anna Kinderkrebsforschung | Chronic Myeloid Leukemia | 2009-04-30 | PHASE2|PHASE3 |
| NCT03656926 | Zambon SpA | Bronchiolitis Obliterans|Chronic Rejection of Lung Transplant|Lung Transplant Rejection|Lung Transplant; Complications|Lung Transplant Failure and Rejection|Chronic Lung Allograft Dysfunction | 2019-03-26 | PHASE3 |
| NCT02864706 | Novartis Pharmaceuticals | Heart Transplantation | 2016-01-18 | PHASE4 |
| NCT06364319 | Peking University People´s Hospital | cGVHD | 2024-04-15 | PHASE4 |
| NCT01180036 | Mayo Clinic|Columbia University|University of British Columbia|Ohio State University|Stanford University|University of Washington|University of Michigan|University of Alabama at Birmingham|Case Western Reserve University|The Cleveland Clinic|University of Kansas Medical Center|University of Manchester|University Health Network, Toronto|University of Toronto|CHU de Quebec-Universite Laval|Washington University School of Medicine|Florida International University|University of Mississippi Medical Center|NYU Langone Health|Medical College of Wisconsin|University of Arizona|Sunnybrook Health Sciences Centre|Applied Health Research Centre|Fulk Family Foundation | Idiopathic Membranous Nephropathy | 2011-11 | PHASE2|PHASE3 |
| NCT00002961 | Children´s Hospital of Philadelphia | Leukemia | 1995-10 | PHASE3 |
| NCT03209219 | Peking Union Medical College Hospital | Beh?et Disease|Uveitis | 2017-06-30 | PHASE3 |
| NCT00840827 | Weill Medical College of Cornell University|Celgene | Myelodysplastic Syndrome | 2008-12 | PHASE2 |
| NCT05353101 | Second Affiliated Hospital of Nanchang University | Vernal Keratoconjunctivitis|Cyclosporine 0.05% Eye Drops | 2020-07-01 | PHASE1 |
| NCT00044954 | University of Texas Southwestern Medical Center | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 1999-11 | PHASE2 |
| NCT00797030 | Universidade Federal do Rio de Janeiro | Dry Eye Syndromes|HIV Seropositivity | 2006-10 | PHASE4 |
| NCT00136903 | Mesoblast, Inc. | Graft Vs Host Disease | 2005-04-27 | PHASE2 |
| NCT04988256 | University of Southern California | DRESS Syndrome|Drug-Induced Hypersensitivity Syndrome | 2021-09-27 | EARLY_PHASE1 |
| NCT00008307 | Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 1998-04 | PHASE2 |
| NCT00977977 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Nephrotic Syndrome|Proteinuria|Autoimmune Disease|Glomerular Disease|Membranous Glomerulonephritis | 2010-12-22 | PHASE2 |
| NCT00520130 | National Cancer Institute (NCI) | Myelodysplastic Syndrome|Hodgkin´s Lymphoma|Non-Hodgkin´s Disease|Acute Leukemia|Multiple Myeloma | 2007-10-30 | PHASE1|PHASE2 |
| NCT00112593 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia|Acute Undifferentiated Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Grade III Lymphomatoid Granulomatosis|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Aggressive NK-cell Leukemia|AIDS-related Diffuse Large Cell Lymphoma|AIDS-related Diffuse Mixed Cell Lymphoma|AIDS-related Diffuse Small Cleaved Cell Lymphoma|AIDS-related Immunoblastic Large Cell Lymphoma|AIDS-related Lymphoblastic Lymphoma|AIDS-related Peripheral+Systemic Lymphoma|AIDS-related Primary CNS Lymphoma|AIDS-related Small Noncleaved Cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Blastic Phase Chronic Myelogenous Leukemia|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Grade III Lymphomatoid Granulomatosis|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Chronic Eosinophilic Leukemia|Chronic Myelomonocytic Leukemia|Chronic Neutrophilic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular Lymphoma|Contiguous Stage II Grade 3 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|Contiguous Stage II Marginal Zone Lymphoma|Contiguous Stage II Small Lymphocytic Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Essential Thrombocythemia|Extramedullary Plasmacytoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|HIV Infection|HIV-associated Hodgkin Lymphoma|Intraocular Lymphoma|Isolated Plasmacytoma of Bone|Juvenile Myelomonocytic Leukemia|Mast Cell Leukemia|Meningeal Chronic Myelogenous Leukemia|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Myeloid+NK-cell Acute Leukemia|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Burkitt Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Grade 1 Follicular Lymphoma|Noncontiguous Stage II Grade 2 Follicular Lymphoma|Noncontiguous Stage II Grade 3 Follicular Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Noncontiguous Stage II Marginal Zone Lymphoma|Noncontiguous Stage II Small Lymphocytic Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Polycythemia Vera|Post-transplant Lymphoproliferative Disorder|Previously Treated Myelodysplastic Syndromes|Primary Central Nervous System Lymphoma|Primary Myelofibrosis|Primary Systemic Amyloidosis|Progressive Hairy Cell Leukemia, Initial Treatment|Prolymphocytic Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage 0 Chronic Lymphocytic Leukemia|Stage I Adult Burkitt Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Mixed Cell Lymphoma|Stage I Adult Diffuse Small Cleaved Cell Lymphoma|Stage I Adult Hodgkin Lymphoma|Stage I Adult Immunoblastic Large Cell Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage I Adult T-cell Leukemia+Lymphoma|Stage I Childhood Anaplastic Large Cell Lymphoma|Stage I Childhood Hodgkin Lymphoma|Stage I Childhood Large Cell Lymphoma|Stage I Childhood Lymphoblastic Lymphoma|Stage I Childhood Small Noncleaved Cell Lymphoma|Stage I Chronic Lymphocytic Leukemia|Stage I Cutaneous T-cell Non-Hodgkin Lymphoma|Stage I Grade 1 Follicular Lymphoma|Stage I Grade 2 Follicular Lymphoma|Stage I Grade 3 Follicular Lymphoma|Stage I Mantle Cell Lymphoma|Stage I Marginal Zone Lymphoma|Stage I Multiple Myeloma|Stage I Small Lymphocytic Lymphoma|Stage IA Mycosis Fungoides+Sezary Syndrome|Stage IB Mycosis Fungoides+Sezary Syndrome|Stage II Adult Hodgkin Lymphoma|Stage II Adult T-cell Leukemia+Lymphoma|Stage II Childhood Anaplastic Large Cell Lymphoma|Stage II Childhood Hodgkin Lymphoma|Stage II Childhood Large Cell Lymphoma|Stage II Childhood Lymphoblastic Lymphoma|Stage II Childhood Small Noncleaved Cell Lymphoma|Stage II Chronic Lymphocytic Leukemia|Stage II Cutaneous T-cell Non-Hodgkin Lymphoma|Stage II Multiple Myeloma|Stage IIA Mycosis Fungoides+Sezary Syndrome|Stage IIB Mycosis Fungoides+Sezary Syndrome|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Hodgkin Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Adult T-cell Leukemia+Lymphoma|Stage III Childhood Anaplastic Large Cell Lymphoma|Stage III Childhood Hodgkin Lymphoma|Stage III Childhood Large Cell Lymphoma|Stage III Childhood Lymphoblastic Lymphoma|Stage III Childhood Small Noncleaved Cell Lymphoma|Stage III Chronic Lymphocytic Leukemia|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Multiple Myeloma|Stage III Small Lymphocytic Lymphoma|Stage IIIA Mycosis Fungoides+Sezary Syndrome|Stage IIIB Mycosis Fungoides+Sezary Syndrome|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-cell Leukemia+Lymphoma|Stage IV Childhood Anaplastic Large Cell Lymphoma|Stage IV Childhood Hodgkin Lymphoma|Stage IV Childhood Large Cell Lymphoma|Stage IV Childhood Lymphoblastic Lymphoma|Stage IV Childhood Small Noncleaved Cell Lymphoma|Stage IV Chronic Lymphocytic Leukemia|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Small Lymphocytic Lymphoma|Stage IVA Mycosis Fungoides+Sezary Syndrome|Stage IVB Mycosis Fungoides+Sezary Syndrome|T-cell Large Granular Lymphocyte Leukemia|Testicular Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific|Unspecified Childhood Solid Tumor, Protocol Specific|Waldenstr?m Macroglobulinemia | 1999-11 | NA |
| NCT01427881 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Myeloid Leukemia in Remission|Adult Erythroleukemia (M6a)|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Adult Pure Erythroid Leukemia (M6b)|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Blastic Phase Chronic Myelogenous Leukemia|Childhood Acute Erythroleukemia (M6)|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Megakaryocytic Leukemia (M7)|Childhood Acute Myeloid Leukemia in Remission|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Cutaneous B-cell Non-Hodgkin Lymphoma|de Novo Myelodysplastic Syndromes|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Philadelphia Chromosome Negative Chronic Myelogenous Leukemia|Post-transplant Lymphoproliferative Disorder|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Recurrent+Refractory Childhood Hodgkin Lymphoma|Relapsing Chronic Myelogenous Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage III Multiple Myeloma|Testicular Lymphoma|Waldenstr?m Macroglobulinemia | 2011-09 | PHASE2 |
| NCT00112645 | Milton S. Hershey Medical Center | Neuroblastoma|Sarcoma|Unspecified Childhood Solid Tumor, Protocol Specific | 2005-04 | PHASE1 |
| NCT07239128 | University of Seville|Centro Oculistico Borroni | Dry Eye Disease (DED) | 2024-05-01 | EARLY_PHASE1 |
| NCT00048165 | Hoffmann-La Roche | Heart Transplantation | 1999-08 | PHASE4 |
| NCT01990118 | Penang Hospital, Malaysia | End Stage Renal Failure | 2004-11 | PHASE4 |
| NCT00264355 | University of Oslo School of Pharmacy | Heart Transplantation|Acute Renal Failure | 2005-12 | PHASE4 |
| NCT01690520 | Nohla Therapeutics, Inc.|National Cancer Institute (NCI)|National Heart, Lung, and Blood Institute (NHLBI) | Acute Biphenotypic Leukemia|Acute Lymphoblastic Leukemia in Remission|Acute Myeloid Leukemia in Remission|Chronic Myelogenous Leukemia|Myelodysplastic Syndrome | 2012-12-11 | PHASE2 |
| NCT00022737 | National Cancer Institute (NCI) | Childhood Acute Lymphoblastic Leukemia in Remission|Recurrent Childhood Acute Lymphoblastic Leukemia | 2002-10 | PHASE3 |
| NCT00824811 | M.D. Anderson Cancer Center|Allergan | Epiphora | 2009-06 | PHASE2 |
| NCT02655705 | Seoul National University Hospital | Psoriasis | 2014-08 | PHASE4 |
| NCT00074269 | University of California, San Diego|National Cancer Institute (NCI) | Breast Cancer | 2003-07 | PHASE2 |
| NCT00017654 | Northwestern Memorial Hospital | Graft Versus Host Disease|Aplastic Anemia | 2001-04 | NA |
| NCT01129739 | Shandong University|National Natural Science Foundation of China | Myelodysplastic Syndromes | 2010-05 | PHASE2 |
| NCT00784719 | Pfizer | Dry Eye Syndromes | 2008-11 | PHASE1|PHASE2 |
| NCT00959231 | Cancer Research UK | Hematopoietic+Lymphoid Cancer | 2009-01 | PHASE2 |
| NCT00031070 | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections | | PHASE2 |
| NCT00056095 | UNICANCER | Kidney Cancer | 2002-11-04 | PHASE2 |
| NCT07566377 | Memorial Sloan Kettering Cancer Center | Acute Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndromes|Non-hodgkin Lymphoma|Hodgkin Lymphoma|Leukemia|Lymphoma|Graft-versus-host Disease | 2026-04-28 | PHASE2 |
| NCT01650662 | Mario Negri Institute for Pharmacological Research|Heart Care Foundation | Acute Myocardial Infarction | 2012-01 | PHASE3 |
| NCT05696977 | Alexandria University | Nephrotic Syndrome | 2022-04-17 | PHASE4 |
| NCT00547196 | City of Hope Medical Center|National Cancer Institute (NCI) | Leukemia|Lymphoma|Myelodysplastic Syndromes | 2005-08-16 | NA |
| NCT00245037 | OHSU Knight Cancer Institute|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms|Precancerous Condition | 2005-06 | PHASE1|PHASE2 |
| NCT00064701 | Astellas Pharma Inc | Kidney Transplantation | 2003-06 | PHASE3 |
| NCT00186628 | Stanford University|The Leukemia and Lymphoma Society|National Cancer Institute (NCI) | Leukemia, Mast-Cell|Mantle-cell Lymphoma | 2005-06 | PHASE2 |
| NCT00004323 | National Center for Research Resources (NCRR)|University of California, Los Angeles | Aplastic Anemia | 1995-02 | PHASE2 |
| NCT00328653 | Santen SAS | Conjunctivitis, Vernal | 2006-05 | PHASE2|PHASE3 |
| NCT03657342 | Zambon SpA | Bronchiolitis Obliterans|Chronic Rejection of Lung Transplant|Lung Transplant Rejection|Lung Transplant; Complications|Lung Transplant Failure and Rejection|Chronic Lung Allograft Dysfunction | 2019-03-26 | PHASE3 |
| NCT05936086 | shifeng Lou | Hemophagocytic Syndrome | 2023-04-20 | NA |
| NCT04304820 | National Heart, Lung, and Blood Institute (NHLBI) | Severe Aplastic Anemia | 2020-05-07 | PHASE2 |
| NCT00571662 | University of Nebraska|Astex Pharmaceuticals, Inc. | Acute Myelogenous Leukemia|Acute Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Chronic Lymphocytic Leukemia|Myelodysplastic Syndromes|Multiple Myeloma|Non-Hodgkins Lymphoma|Hodgkins Disease|Peripheral T-cell Lymphoma | 2000-12-08 | PHASE2 |
| NCT00891306 | Amsterdam Molecular Therapeutics|The Clinical Trial Company | Familial Lipoprotein Lipase Deficiency | 2009-02 | PHASE2|PHASE3 |
| NCT00000936 | National Institute of Allergy and Infectious Diseases (NIAID) | Kidney Transplantation | 1999-11 | PHASE3 |
| NCT01429844 | Universit?tsklinikum Hamburg-Eppendorf | Bronchiolitis Obliterans|Immunosuppression | 2001-01 | PHASE3 |
| NCT06043908 | Peking University Third Hospital | Dry Eye | 2022-08-31 | PHASE4 |
| NCT00542152 | Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives | Ulcerative Colitis|Steroid Refractory | 2007-06 | PHASE4 |
| NCT00027820 | Fred Hutchinson Cancer Center|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI) | Adult Acute Myeloid Leukemia in Remission|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Myelodysplastic Syndrome|Childhood Renal Cell Carcinoma|Chronic Myelomonocytic Leukemia|Clear Cell Renal Cell Carcinoma|de Novo Myelodysplastic Syndrome|Metastatic Renal Cell Cancer|Previously Treated Myelodysplastic Syndrome|Progression of Multiple Myeloma or Plasma Cell Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult Non-Hodgkin Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Non-Hodgkin Lymphoma|Refractory Anemia|Refractory Anemia With Ringed Sideroblasts|Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Renal Medullary Carcinoma|Type 1 Papillary Renal Cell Carcinoma|Type 2 Papillary Renal Cell Carcinoma|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Adult Acute Myeloid Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia | 2001-08 | PHASE1|PHASE2 |
| NCT04149678 | Celgene | Healthy Volunteers | 2019-10-04 | PHASE1 |
| NCT00653276 | Organon and Co|Schering-Plough | Cholesterol | 2003-11 | PHASE1 |
| NCT02745717 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine|Ruijin Hospital|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|Shanghai Tongji Hospital, Tongji University School of Medicine|Zhejiang Provincial Hospital of TCM | Severe Aplastic Anemia | 2016-01 | PHASE4 |
| NCT02274662 | Sumitomo Pharma Switzerland GmbH | Poor Thymic Function|Immunodeficiency|Athymia|Immunoreconstitution|Thymus Transplantation|Low T Cell Numbers | 2014-08 | PHASE4 |
| NCT06013423 | Fred Hutchinson Cancer Center|National Cord Blood Network | Acute Leukemia of Ambiguous Lineage|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Blastic Plasmacytoid Dendritic Cell Neoplasm|Hematopoietic and Lymphatic System Neoplasm|Mixed Phenotype Acute Leukemia|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Non-Hodgkin Lymphoma|Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2024-07-23 | PHASE2 |
| NCT00157014 | Astellas Pharma Inc|Astellas Pharma Canada, Inc. | Heart Diseases|Heart Transplantation | 2004-05-10 | PHASE3 |
| NCT03013933 | City of Hope Medical Center|National Cancer Institute (NCI) | Recurrent Hodgkin Lymphoma|Refractory Hodgkin Lymphoma | 2017-05-03 | PHASE1 |
| NCT00038948 | Wyeth is now a wholly owned subsidiary of Pfizer | Renal Transplantation | 2002-01 | PHASE3 |
| NCT00118352 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Acute Undifferentiated Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Juvenile Myelomonocytic Leukemia|Mast Cell Leukemia|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Recurrent+Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Relapsing Chronic Myelogenous Leukemia|Secondary Myelodysplastic Syndromes|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Testicular Lymphoma|Waldenstr?m Macroglobulinemia | 2005-03 | PHASE2 |
| NCT07548671 | Peking Union Medical College Hospital | Transfusion-dependent Non-severe Aplastic Anemia | 2026-04 | PHASE3 |
| NCT00004232 | Northwestern University|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Precancerous+Nonmalignant Condition | 1999-10 | PHASE1 |
| NCT00766909 | University of Aarhus | Complications of Transplanted Organs and Tissue|Diabetes Mellitus Nos New Onset | 2008-03 | PHASE4 |
| NCT00054353 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Refractory Multiple Myeloma | 2002-10 | PHASE1|PHASE2 |
| NCT00281983 | German CLL Study Group | Chronic Lymphocytic Leukemia | 2000-06 | PHASE1|PHASE2 |
| NCT00003954 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Refractory Multiple Myeloma|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple Myeloma | 1999-03 | PHASE1|PHASE2 |
| NCT00425802 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Leukemia|Lymphoma | 2006-11-28 | PHASE2 |
| NCT00006184 | National Cancer Institute (NCI) | Multiple Myeloma | 2001-02-08 | PHASE2 |
| NCT00518375 | Wyeth is now a wholly owned subsidiary of Pfizer | Kidney Transplantation | 2000-04 | PHASE4 |
| NCT07566975 | Neuro-Ophthalmology of Texas|Harrow Inc | Dry Eye | 2026-03-31 | |
| NCT00301834 | University of California, San Francisco|National Cancer Institute (NCI) | Congenital Amegakaryocytic Thrombocytopenia|Diamond-blackfan Anemia|Leukemia|Myelodysplastic Syndromes|Severe Congenital Neutropenia | 2005-01 | PHASE2 |
| NCT00093587 | Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) | Graft Versus Host Disease|Leukemia | 2004-08 | NA |
| NCT00119392 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | B-cell Chronic Lymphocytic Leukemia|Nodal Marginal Zone B-cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Splenic Marginal Zone Lymphoma|Waldenstr?m Macroglobulinemia | 2004-06 | PHASE2 |
| NCT00896493 | Stanford University | Mycoses|Sezary Syndrome|Lymphoma, T-Cell, Cutaneous|Bone Marrow Transplant Failure|Lymphoma, Non-Hodgkin|Cutaneous T-cell Lymphoma | 2009-05 | PHASE2 |
| NCT00322101 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI)|National Heart, Lung, and Blood Institute (NHLBI) | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Acute Myeloid Leukemia+Transient Myeloproliferative Disorder|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Childhood Acute Myeloid Leukemia in Remission|Childhood Myelodysplastic Syndromes|de Novo Myelodysplastic Syndromes|Myelodysplastic Syndrome With Isolated Del(5q)|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes | 2006-01 | PHASE3 |
| NCT00578643 | Baylor College of Medicine | Chronic Granulomatous Disease | 2004-03 | PHASE2 |
| NCT00036738 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Adult Acute Lymphoblastic Leukemia in Remission|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Blastic Phase|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Phase of Disease|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Disease | 2001-07-13 | PHASE2 |
| NCT00005940 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | 1999-10 | PHASE2 |
| NCT00637143 | Astellas Pharma Inc|Astellas Pharma Canada, Inc. | Renal Transplantation|Chronic Renal Allograft Failure | 1999-04 | PHASE4 |
| NCT00419926 | Novartis | Kidney Transplantation | 2006-12 | PHASE4 |
| NCT00020176 | National Cancer Institute (NCI) | Breast Cancer | 2000-06 | PHASE2 |
| NCT04009525 | First Affiliated Hospital of Guangxi Medical University|Peking University People´s Hospital|Ruijin Hospital|The 923rd Hospital of Joint Logistics Support Force of People´s Liberation Army|LiuZhou People´s Hospital|The First People´s Hospital of Yunnan|Liuzhou Workers´ Hospital|Xinqiao Hospital of Chongqing|Affiliated Hospital of Youjiang University of Ethnic Medicine|Hainan People´s Hospital|Maoming People´s Hospital|Red Cross Hospital of Yulin City|Guilin Medical College|Wuzhou People´s Hospital|Guangxi Autonomous Region People´s Hospital|The 920th Hospital of Joint Logistics Support Force of People´s Liberation Army | Thalassemia Major | 2019-07-05 | PHASE4 |
| NCT00938236 | APT Pharmaceuticals, Inc. | Lung Transplant | 2009-12 | PHASE3 |
| NCT06482177 | Research Insight LLC | Dry Eye | 2023-10-12 | PHASE4 |
| NCT01426334 | National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Phase Chronic Myelogenous Leukemia|Relapsing Chronic Myelogenous Leukemia | 2011-09 | PHASE1 |
| NCT00195273 | Wyeth is now a wholly owned subsidiary of Pfizer | Graft vs Host Disease|Kidney Transplantation | 2004-11 | PHASE3 |
| NCT00611403 | Allergan | Dry Eye Syndromes | 2007-12 | PHASE2 |
| NCT00154193 | Novartis Pharmaceuticals | Heart and Lung Transplant | 2004-06 | PHASE4 |
| NCT07397936 | Samsung Medical Center | Dry Eye Disease (DED)|Cataract | 2024-08-01 | PHASE4 |
| NCT01289301 | Hannover Medical School | Disorder Related to Renal Transplantation|Immunosuppression Related Infectious Disease|Virus Diseases | 2011-10 | PHASE4 |
| NCT00010361 | Fred Hutchinson Cancer Center | Metabolism, Inborn Errors|Granulomatous Disease, Chronic | 2000-11 | NA |
| NCT02225756 | Assistance Publique - H?pitaux de Paris | Abdominal Aortic Aneurysm,|Small Abdominal Aortic Aneurysm | 2013-12 | PHASE2 |
| NCT00002761 | Columbia University | Leukemia | 1996-02 | PHASE1|PHASE2 |
| NCT00002792 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Leukemia|Myelodysplastic+Myeloproliferative Diseases | 1996-06 | PHASE2 |
| NCT04835623 | Center for Ophthalmic and Vision Research, LLC|Sun Pharmaceutical Industries Limited | Dry Eye|Dry Eye Syndromes|Sjogren´s Syndrome | 2021-06-21 | PHASE4 |
| NCT00060424 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | B-Cell Prolymphocytic Leukemia|Chronic Lymphocytic Leukemia|Prolymphocytic Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|T-Cell Prolymphocytic Leukemia | 2003-03 | PHASE2 |
| NCT00043979 | National Cancer Institute (NCI) | Sarcoma | 2002-09-19 | PHASE2 |
| NCT00260208 | Novartis Pharmaceuticals | Liver Transplant|Hepatitis C | 2006-01 | PHASE4 |
| NCT00008021 | University of California, Davis | Lymphoma | 2001-02 | PHASE1 |
| NCT00003060 | Louisiana State University Health Sciences Center Shreveport | Melanoma (Skin) | 1995-03 | PHASE1 |
| NCT01370343 | Pfizer | Healthy|Drug Interaction | 2011-07 | PHASE1 |
| NCT00031655 | Fred Hutchinson Cancer Research Center+University of Washington Cancer Consortium|National Cancer Institute (NCI) | Adult Acute Lymphoblastic Leukemia in Remission|Childhood Acute Lymphoblastic Leukemia in Remission|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia | 2001-09 | PHASE2 |
| NCT00755040 | Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms | 2008-10 | PHASE3 |
| NCT00556257 | Pfizer | Kidney Transplantation | 2007-08 | PHASE2 |
| NCT00008177 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Chronic Myelomonocytic Leukemia|de Novo Myelodysplastic Syndromes|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Myeloid Leukemia|Refractory Anemia With Excess Blasts|Refractory Anemia With Excess Blasts in Transformation|Refractory Anemia With Ringed Sideroblasts|Refractory Cytopenia With Multilineage Dysplasia|Secondary Myelodysplastic Syndromes|Untreated Adult Acute Myeloid Leukemia | 1999-07-27 | PHASE1 |
| NCT00636909 | Beth Israel Deaconess Medical Center|Amgen | AML|ALL|CML Chronic Phase, Accelerated Phase, or Blast Crisis|CLL|MDS|RELAPSED NON-HODGKIN´S OR HODGKIN´S LYMPHOMA|APLASTIC ANEMIA|MULTIPLE MYELOMA|MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET) | 1999-07 | PHASE2 |
| NCT06541678 | Pfizer | Healthy | 2024-12-23 | PHASE1 |
| NCT07523009 | Peking Union Medical College Hospital | Severe Aplastic Anemia (SAA)|Transfusion-dependent Non-severe Aplastic Anemia | 2026-04 | PHASE2 |
| NCT00150085 | Novartis | Tacrolimus-associated Abnormal Glucose Metabolism in Kidney and Liver Transplant Recipients | 2004-02 | PHASE4 |
| NCT00027443 | Mayo Clinic | Myocarditis | 2001-08 | NA |
| NCT00110058 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia | 2005-02 | PHASE2 |
| NCT00003187 | Virginia Commonwealth University|National Cancer Institute (NCI) | Leukemia|Lymphoma|Myelodysplastic Syndromes | 1995-05 | PHASE2|PHASE3 |
| NCT02686619 | Hoffmann-La Roche | Renal Transplantation | 2004-11 | PHASE3 |
| NCT00376519 | Masonic Cancer Center, University of Minnesota | Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Secondary Myelofibrosis | 2007-05 | PHASE1 |
| NCT01762657 | Perle Bioscience, Inc. | Type 1 Diabetes | 2014-09 | PHASE3 |
| NCT00006054 | Fairview University Medical Center | Immunologic Deficiency Syndromes|Chediak-Higashi Syndrome|Common Variable Immunodeficiency|Graft Versus Host Disease|X-Linked Lymphoproliferative Syndrome|Familial Erythrophagocytic Lymphohistiocytosis|Hemophagocytic Lymphohistiocytosis|X-linked Agammaglobulinemia|Wiskott-Aldrich Syndrome|Chronic Granulomatous Disease|X-linked Hyper IgM Syndrome|Severe Combined Immunodeficiency|Leukocyte Adhesion Deficiency Syndrome|Virus-Associated Hemophagocytic Syndrome | 2000-03 | NA |
| NCT01954784 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) | Refractory Multiple Myeloma|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple Myeloma | 2013-10-07 | PHASE1 |
| NCT00055653 | Roswell Park Cancer Institute|National Heart, Lung, and Blood Institute (NHLBI) | Leukemia|Lymphoma|Myelodysplastic Syndromes|Myelodysplastic-Myeloproliferative Diseases | 2003-01 | PHASE2 |
| NCT01266148 | Novartis Pharmaceuticals | Renal Function and Chronic Allograft Vasculopathy | 2009-11 | PHASE4 |
| NCT00024128 | AIDS Malignancy Consortium|National Cancer Institute (NCI) | Lymphoma | 2001-08 | PHASE2 |
| NCT01810926 | Franco Locatelli|University of Milano Bicocca|medac GmbH|Fresenius AG | Graft Versus Host Disease | 2011-09 | PHASE2 |
| NCT00139035 | University of Oslo School of Pharmacy | Chronic Renal Failure | 2005-04 | PHASE4 |
| NCT00080925 | National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms | 2004-02 | PHASE1 |
| NCT01392989 | Everett Meyer | Neural Tube Defects|Anemia|Leukemia, Myeloid|Bone Marrow Transplant Failure|Myelodysplastic Syndromes (MDS)|Myeloproliferative Disorders | 2011-03 | PHASE2 |
| NCT00874315 | Nationwide Children´s Hospital | Neuroblastoma | 2008-09 | PHASE2 |
| NCT00594308 | Indiana University | Acute Myelogenous Leukemia|Acute Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Chronic Lymphocytic Leukemia|Myelodysplasia|Lymphoma, Non-Hodgkin´s|Mantle-Cell Lymphoma|Hodgkin´s Disease|Multiple Myeloma|Myelofibrosis | 2007-10 | NA |
| NCT00024050 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia|Myelodysplastic Syndromes | 2001-02 | PHASE2 |
| NCT04412785 | University of Pennsylvania | COVID-19 | 2020-06-30 | PHASE1 |
| NCT00553735 | Massachusetts Eye and Ear Infirmary | Dry Eye | 2007-08 | PHASE4 |
| NCT00425724 | Oulu University Hospital | Purpura, Schoenlein-Henoch | 2000-01 | PHASE4 |
| NCT00005803 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Prolymphocytic Leukemia|Recurrent Adult Hodgkin Lymphoma|Recurrent Childhood Hodgkin Lymphoma|Recurrent Childhood Non-Hodgkin Lymphoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Non-Hodgkin Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hodgkin Lymphoma|Refractory Non-Hodgkin Lymphoma|Refractory Small Lymphocytic Lymphoma|T-Cell Chronic Lymphocytic Leukemia|T-Cell Prolymphocytic Leukemia | 1999-09 | PHASE1|PHASE2 |
| NCT00974142 | Michael Donahoe|National Heart, Lung, and Blood Institute (NHLBI) | Chronic Obstructive Pulmonary Disease | 2009-09 | PHASE1|PHASE2 |
| NCT00002789 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia | 1996-05 | PHASE3 |
| NCT00295425 | University Hospital Muenster|Hoffmann-La Roche | Psoriasis | 2000-05 | PHASE2 |
| NCT01514968 | Hoffmann-La Roche | Healthy Volunteer | 2011-12 | PHASE1 |
| NCT00006968 | Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) | Kidney Cancer | 2000-09 | PHASE1|PHASE2 |
| NCT00066417 | National Heart, Lung, and Blood Institute (NHLBI) | Chronic Myeloproliferative Disorders|Leukemia|Myelodysplastic+Myeloproliferative Diseases | | PHASE2 |
| NCT01276457 | Novartis Pharmaceuticals | Transplantation Infection | 2006-05 | PHASE3 |
| NCT00253552 | OHSU Knight Cancer Institute|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases|Sarcoma | 2004-05 | NA |
| NCT04039347 | Zambon SpA | Bronchiolitis Obliterans|Obliterative Bronchiolitis|Bronchiolitis Obliterans Syndrome | 2020-03-12 | PHASE3 |
| NCT05398653 | Beijing Mabworks Biotech Co., Ltd. | Primary Membranous Nephropathy | 2022-02-24 | PHASE1|PHASE2 |
| NCT00031980 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Anemia|Leukemia|Neutropenia|Thrombocytopenia | 2002-03 | PHASE2 |
| NCT04781803 | Hospital Universitario Dr. Jose E. Gonzalez | Stem Cell Transplant Complications|Cytokine Release Syndrome | 2021-03-25 | PHASE2 |
| NCT01193283 | National Heart, Lung, and Blood Institute (NHLBI) | Aplastic Anemia|Neutropenia|Pancytopenia|Severe Aplastic Anemia | 2010-08 | PHASE1|PHASE2 |
| NCT00290641 | Masonic Cancer Center, University of Minnesota|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Myelodysplastic Syndromes | 2001-04 | NA |
| NCT00812786 | University Hospital, Limoges | Heart Transplant | 2007-07 | PHASE4 |
| NCT00789308 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Clinical Islet Transplantation Consortium | Diabetes Mellitus, Type I | 2008-07-11 | PHASE2 |
| NCT00298324 | European Society for Blood and Marrow Transplantation|Novartis | Graft vs Host Disease | 2006-09 | PHASE3 |
| NCT01231841 | The Cleveland Clinic | Aplastic Anemia | 2005-03 | PHASE2 |
| NCT00483756 | Pfizer | Kidney Transplantation | 2007-08 | PHASE2 |
| NCT01273207 | National Heart, Lung, and Blood Institute (NHLBI) | Bronchiolitis Obliterans|Constructive Bronchiolitis|Graft Versus Host Disease|Bronchiolitis, Exudative|Bronchiolitis, Proliferative|Graft-Versus-Host Disease | 2012-03-02 | PHASE2 |
| NCT02660684 | Astellas Pharma Korea, Inc. | Graft Versus Host Disease | 2008-02 | PHASE4 |
| NCT00976300 | Institute of Rheumatology, Prague|Ministry of Health, Czech Republic|Charles University, Czech Republic|Palacky University|Department of Rheumatology, Hospital, Ceske Budejovice, Czech Republic|National Institute of Rheumatology, Piestany, Slovakia|St. Anna Hospital, Brno, Czech | Systemic Lupus Erythematosus|Lupus Nephritis | 2002-01 | PHASE2 |
| NCT03095547 | F2G Biotech GmbH|Bio-Kinetic Europe, Ltd. | Invasive Aspergillosis | 2017-05 | PHASE1 |
| NCT00568633 | Stanford University|Genzyme, a Sanofi Company | Leukemia, Myeloid|Leukemia|Acute Myeloid Leukemia (AML) | 2007-08 | PHASE3 |
| NCT00574496 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Lymphoma | 2007-11-13 | PHASE2 |
| NCT00185614 | Wen-Kai Weng | Blood Cancer|Multiple Myeloma | 2000-08 | PHASE2 |
| NCT04542252 | SymBio Pharmaceuticals | Drug Drug Interaction | 2020-11-09 | PHASE1 |
| NCT00741455 | Dartmouth-Hitchcock Medical Center | Hematologic Malignancies | 2004-06 | NA |
| NCT05720715 | Farwaniya Hospital | Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis | 2022-01-01 | PHASE4 |
| NCT02424968 | Robert Lowsky|National Cancer Institute (NCI) | Acute Myeloid Leukemia|B-Cell Non-Hodgkin Lymphoma|Chronic Lymphocytic Leukemia|Hodgkin Lymphoma|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|T-Cell Non-Hodgkin Lymphoma | 2015-06 | PHASE2 |
| NCT01494597 | Astellas Pharma Inc|Basilea Pharmaceutica International Ltd | Healthy | 2011-11 | PHASE1 |
| NCT00005935 | National Heart, Lung, and Blood Institute (NHLBI) | Aplastic Anemia | 2000-06 | PHASE2 |
| NCT01446484 | Pirogov Russian National Research Medical University|Russian Academy of Medical Sciences | End-Stage Renal Disease|Kidney Failure | 2011-10 | PHASE1|PHASE2 |
| NCT05862233 | Beijing Mabworks Biotech Co., Ltd. | Primary Membranous Nephropathy | 2023-06-02 | PHASE3 |
| NCT00377325 | University of Rochester|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Psoriasis | 2007-06 | PHASE2 |
| NCT07171710 | Tianjin Eye Hospital | Dry Eye Disease | 2024-03-01 | NA |
| NCT00005113 | Boston Children´s Hospital | End-Stage Renal Disease|Kidney Transplantation | 1999-07 | PHASE3 |
| NCT01789255 | National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Grade III Lymphomatoid Granulomatosis|B-cell Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular Lymphoma|Contiguous Stage II Grade 3 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|Contiguous Stage II Marginal Zone Lymphoma|Contiguous Stage II Small Lymphocytic Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Graft Versus Host Disease|Intraocular Lymphoma|Myelodysplastic Syndrome With Isolated Del(5q)|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Burkitt Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Grade 1 Follicular Lymphoma|Noncontiguous Stage II Grade 2 Follicular Lymphoma|Noncontiguous Stage II Grade 3 Follicular Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Noncontiguous Stage II Marginal Zone Lymphoma|Noncontiguous Stage II Small Lymphocytic Lymphoma|Post-transplant Lymphoproliferative Disorder|Primary Central Nervous System Hodgkin Lymphoma|Primary Central Nervous System Non-Hodgkin Lymphoma|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Anemia|Refractory Anemia With Excess Blasts|Refractory Anemia With Ringed Sideroblasts|Refractory Chronic Lymphocytic Leukemia|Refractory Cytopenia With Multilineage Dysplasia|Refractory Hairy Cell Leukemia|Relapsing Chronic Myelogenous Leukemia|Secondary Central Nervous System Hodgkin Lymphoma|Secondary Central Nervous System Non-Hodgkin Lymphoma|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage I Adult Burkitt Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Mixed Cell Lymphoma|Stage I Adult Diffuse Small Cleaved Cell Lymphoma|Stage I Adult Hodgkin Lymphoma|Stage I Adult Immunoblastic Large Cell Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage I Chronic Lymphocytic Leukemia|Stage I Grade 1 Follicular Lymphoma|Stage I Grade 2 Follicular Lymphoma|Stage I Grade 3 Follicular Lymphoma|Stage I Mantle Cell Lymphoma|Stage I Marginal Zone Lymphoma|Stage I Small Lymphocytic Lymphoma|Stage II Adult Hodgkin Lymphoma|Stage II Chronic Lymphocytic Leukemia|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Hodgkin Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Chronic Lymphocytic Leukemia|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Chronic Lymphocytic Leukemia|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Small Lymphocytic Lymphoma|Testicular Lymphoma|Waldenstr?m Macroglobulinemia | 2013-06 | PHASE2 |
| NCT04734197 | Surface Ophthalmics, Inc. | Dry Eye Disease | 2021-01-11 | PHASE2 |
| NCT00003335 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) | Graft Versus Host Disease|Leukemia|Lymphoma|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 1998-01 | PHASE2 |
| NCT02144025 | Hospital Universitario Dr. Jose E. Gonzalez | Graft-Versus-Host Disease | 2014-05 | PHASE2 |
| NCT00420537 | University of Bologna | Kidney Dysfunction|Heart Transplantation | 2006-09 | PHASE4 |
| NCT04555694 | Thomas Chester, OD | Dry Eye | 2020-10-01 | PHASE4 |
| NCT00619645 | University of California, Davis | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 2007-06 | PHASE2 |
| NCT00087581 | Hoffmann-La Roche | Kidney Transplantation | 2004-06 | PHASE4 |
| NCT01288131 | Chulalongkorn University | Anti-r-HuEpo Associated PRCA Subjects | 2009-01 | PHASE3 |
| NCT00790439 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Diabetes Mellitus, Type I | 2008-07 | PHASE2 |
| NCT06752694 | Fred Hutchinson Cancer Center|Incyte Corporation | Aplastic Anemia | 2025-09-25 | PHASE2 |
| NCT02144857 | University of Athens | Psoriasis | 2014-05-30 | PHASE4 |
| NCT01479881 | Tibotec Pharmaceuticals, Ireland | Hepatitis C Virus | 2011-10 | PHASE1 |
| NCT00343798 | Fred Hutchinson Cancer Center|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI)|Damon Runyon Cancer Research Foundation | Accelerated Phase Chronic Myelogenous Leukemia|Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Chronic Phase Chronic Myelogenous Leukemia|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage II Grade 3 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|de Novo Myelodysplastic Syndromes|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Burkitt Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Grade 3 Follicular Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Previously Treated Myelodysplastic Syndromes|Prolymphocytic Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Anemia|Refractory Anemia With Excess Blasts|Refractory Anemia With Excess Blasts in Transformation|Refractory Chronic Lymphocytic Leukemia|Refractory Multiple Myeloma|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Splenic Marginal Zone Lymphoma|Stage I Adult Burkitt Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Mixed Cell Lymphoma|Stage I Adult Immunoblastic Large Cell Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage I Childhood Lymphoblastic Lymphoma|Stage I Grade 3 Follicular Lymphoma|Stage I Mantle Cell Lymphoma|Stage II Childhood Lymphoblastic Lymphoma|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Childhood Lymphoblastic Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Childhood Lymphoblastic Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma | 2006-04 | PHASE1 |
| NCT00793572 | Fred Hutchinson Cancer Center|Millennium Pharmaceuticals, Inc.|National Cancer Institute (NCI) | Refractory Plasma Cell Myeloma | 2008-10 | PHASE2 |
| NCT00290628 | Masonic Cancer Center, University of Minnesota|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Diamond-blackfan Anemia|Fanconi Anemia|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 1999-10 | NA |
| NCT04714099 | Alexandria University | Dry Eye | 2015-01-01 | PHASE3 |
| NCT07352566 | University of California, San Francisco | Psoriasis|Atopic Dermatitis | 2026-01-01 | PHASE4 |
| NCT01020734 | Asan Medical Center | Leukemia | 2011-05 | PHASE2 |
| NCT00005898 | University of Minnesota | Fanconi´s Anemia | 2000-02 | PHASE1|PHASE2 |
| NCT06005714 | Shanghai Vinnerna Biosciences Co., Ltd. | The Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese Subjects | 2023-08-15 | PHASE1 |
| NCT00821587 | University of Florida|Novartis Pharmaceuticals | Hepatitis C | 2004-06 | PHASE4 |
| NCT04530487 | M.D. Anderson Cancer Center | Desmoplastic Small Round Cell Tumor|Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor|Recurrent Desmoplastic Small Round Cell Tumor|Recurrent Malignant Peripheral Nerve Sheath Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Neuroblastoma|Recurrent Rhabdomyosarcoma|Refractory Desmoplastic Small Round Cell Tumor|Refractory Malignant Peripheral Nerve Sheath Tumor|Refractory Malignant Solid Neoplasm|Refractory Neuroblastoma|Refractory Rhabdomyosarcoma | 2020-08-19 | PHASE2 |
| NCT00972660 | Guangdong Provincial People´s Hospital|Sun Yat-sen University | Graft Versus Host Disease | 2009-09 | PHASE2 |
| NCT00349440 | Innovative Medical | Dry Eye Syndromes | 2006-09 | PHASE4 |
| NCT00110110 | The Hospital for Sick Children|Terry Fox Foundation | Retinoblastoma | 2004-06 | PHASE2 |
| NCT00729768 | Genentech, Inc. | Kidney Transplantation | | PHASE2|PHASE3 |
| NCT00004482 | Mayo Clinic | Myocarditis|Giant Cell Myocarditis | 1999-12 | PHASE2 |
| NCT05794425 | Shandong Qilu Stem Cells Engineering Co., Ltd.|Shandong Province Third hospital|Dezhou People´s Hospital|Children´s Hospital Affiliated to Shandong University|The Second Affiliated Hospital of Shandong First Medical University|Taian City Central Hospital|Linyi People´s Hospital|Rizhao People´s Hospital|Lanling People´s Hospital|Jining First People´s Hospital|Affiliated Hospital of Jining Medical University|Zibo Municipal Hospital|Binzhou People´s Hospital|The Affiliated Hospital of Binzhou Medical College|Shengli Oilfield Hospital|Weihai Municipal Hospital|Weihai Central Hospital|Shandong University of Traditional Chinese Medicine|Gansu Provincial Hospital of Traditional Chinese Medicine (TCM)|Wuwei People´s Hospital|Gansu Wuwei Tumor Hospital|The Second Affiliated Hospital of Harbin Medical University|Yuncheng Institute of Hematology|Kaifeng Central Hospital|Zhengzhou Central Hospital|Air Force Hospital of Western War Zone|The First People´ s Hospital of Yunnan Province|Zigong No.1 Peoples Hospital|The First People´s Hospital of Jingzhou|Jiangxi Province Children´s Hospital|Second Affiliated Hospital of Zhengzhou University|Yantai Ludong Hospital (Shandong Provincial Hospital Group) | Bone Marrow Failure Disorders | 2023-08-01 | PHASE1|PHASE2 |
| NCT01650545 | University of Maryland, Baltimore | Disorder Related to Lung Transplantation|Bronchiolitis Obliterans|Decreased Immunologic Activity|Chronic Rejection of Lung Transplant | 2012-07 | PHASE1|PHASE2 |
| NCT01990898 | The Cleveland Clinic | Interstitial Cystitis | 2013-11 | PHASE2 |
| NCT03336632 | Sichuan University | Leukemia, Acute|MDS | 2019-01-01 | PHASE2 |
| NCT00054340 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 2002-10 | PHASE1|PHASE2 |
| NCT00658320 | Novartis | Kidney Transplantation | 2008-02 | PHASE3 |
| NCT00990795 | The University of Texas Health Science Center, Houston | Cardiac Surgical Procedures | 2010-04 | PHASE1 |
| NCT05459649 | Peking University People´s Hospital | Immune Thrombocytopenia | 2022-07-20 | PHASE2 |
| NCT00541814 | University Hospital Birmingham|Novartis | Chronic Allograft Nephropathy | 2007-10 | PHASE4 |
| NCT00507793 | Wyeth is now a wholly owned subsidiary of Pfizer | Kidney Transplantation | 2000-04 | PHASE4 |
| NCT00003116 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 1997-05 | PHASE2 |
| NCT02121847 | Allergan | Dry Eye Syndromes | 2014-04-03 | PHASE4 |
| NCT00719849 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 2005-11 | PHASE2 |
| NCT05600426 | Boston Children´s Hospital|Center for International Blood and Marrow Transplant Research|National Institutes of Health (NIH)|National Heart, Lung, and Blood Institute (NHLBI)|North American Pediatric Aplastic Anemia Consortium|Pediatric Transplantation and Cellular Therapy Consortium|Blood and Marrow Transplant Clinical Trials Network | Severe Aplastic Anemia | 2023-01-25 | PHASE3 |
| NCT02799888 | Affiliated Hospital to Academy of Military Medical Sciences | Graft-versus-host Disease|Hematopoietic Stem Cell Transplantation | 2014-04 | PHASE2 |
| NCT02203396 | Institute of Hematology & Blood Diseases Hospital, China | Aplastic Anemia | 2014-08 | PHASE2 |
| NCT06936462 | Hallym University Kangnam Sacred Heart Hospital | Dry Eye Syndrome (DES) | 2020-01-20 | NA |
| NCT04172961 | Toyos Clinic|Sun Pharmaceutical Industries Limited | Dry Eye | 2020-02-01 | PHASE4 |
| NCT00027560 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms | 2001-07 | PHASE2 |
| NCT00378677 | University Medical Center Groningen | Lung Transplantation|Bronchiolitis Obliterans | 2007-02 | EARLY_PHASE1 |
| NCT00005851 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Recurrent Renal Cell Cancer|Stage IV Renal Cell Cancer | 2000-02 | PHASE1|PHASE2 |
| NCT00983931 | Mutual Pharmaceutical Company, Inc. | Pharmacokinetics|Healthy | 2008-08 | PHASE1 |
| NCT05219656 | Tampere University Hospital | Ulcerative Colitis Acute | 2009-01-01 | |
| NCT01231412 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Aggressive Non-Hodgkin Lymphoma|Chronic Lymphocytic Leukemia|Diffuse Large B-Cell Lymphoma|Hematopoietic and Lymphoid Cell Neoplasm|Indolent Non-Hodgkin Lymphoma|Mantle Cell Lymphoma|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Prolymphocytic Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Plasma Cell Myeloma|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Hodgkin Lymphoma|Small Lymphocytic Lymphoma|T-Cell Chronic Lymphocytic Leukemia|Waldenstrom Macroglobulinemia | 2010-11 | PHASE3 |
| NCT01434472 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Post-Transplant Lymphoproliferative Disorder|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent B-Cell Non-Hodgkin Lymphoma|Recurrent Burkitt Lymphoma|Refractory B-Cell Non-Hodgkin Lymphoma|Refractory Burkitt Lymphoma|Refractory Diffuse Large B-Cell Lymphoma | 2011-11-16 | PHASE2 |
| NCT06348602 | Hospital Universitario Dr. Jose E. Gonzalez | Ocular Graft-versus-host Disease | 2023-08-01 | PHASE1|PHASE2 |
| NCT01023815 | Novartis | de Novo Kidney Transplant Recipients|Renal Transplantation | 2009-04 | PHASE3 |
| NCT00428064 | Wyeth is now a wholly owned subsidiary of Pfizer | Renal Transplantation | 1998-05 | PHASE3 |
| NCT00070187 | Children´s Oncology Group|National Cancer Institute (NCI) | Lymphoma | 2003-11 | PHASE2|PHASE3 |
| NCT04813653 | Tel-Aviv Sourasky Medical Center|Weizmann Institute of Science | Multiple Myeloma in Relapse|Multiple Myeloma, Refractory | 2021-04-18 | PHASE1 |
| NCT00534430 | City of Hope Medical Center|National Cancer Institute (NCI) | Leukemia|Myelodysplastic Syndromes | 2000-02-29 | PHASE2 |
| NCT02478424 | Rabin Medical Center | Graft vs Host Disease | 2015-07 | PHASE2 |
| NCT01299922 | Hospital Universitario Fundación Alcorcón|Hospital Universitario 12 de Octubre|Hospital General Universitario Gregorio Mara?on|Hospital Universitario Ramon y Cajal|Hospital Infanta Sofia|Hospital Universitario Infanta Leonor|Hospital Universitario Reina Sofia de Cordoba|Hospital Regional Universitario Carlos Haya|Hospital Universitario Virgen de la Victoria|University Hospital of the Nuestra Se?ora de Candelaria|University of Guadalajara|Hospital San Pedro de Alcantara|Hospital Juan Canalejo | Lupus Nephritis | 2011-02 | PHASE3 |
| NCT02998645 | Novartis Pharmaceuticals | Severe Aplastic Anemia | 2017-05-11 | PHASE2 |
| NCT02281370 | GlaxoSmithKline | Purpura, Thrombocytopenic, Idiopathic | 2014-11-05 | PHASE1 |
| NCT00027547 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia | 2001-07 | PHASE1|PHASE2 |
| NCT00002547 | Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) | Leukemia|Myelodysplastic Syndromes | 1987-08 | PHASE2 |
| NCT02091414 | Hoffmann-La Roche | Heart Transplantation | 2006-08 | PHASE3 |
| NCT00009763 | University of California, Davis | Breast Cancer | 2001-03 | PHASE1 |
| NCT00907036 | Cancer Research UK | Lymphoma | 2009-07 | PHASE2 |
| NCT00633373 | APT Pharmaceuticals, Inc. | Lung Transplant | | |
| NCT00493194 | University Hospital, Antwerp|Wyeth is now a wholly owned subsidiary of Pfizer|Hoffmann-La Roche | Kidney Failure, Chronic|Transplantation|Immunosuppression|Interstitial Fibrosis | 2005-05 | PHASE4 |
| NCT03750383 | Enanta Pharmaceuticals, Inc|Pharmaceutical Research Associates | RSV Infection | 2018-11-02 | PHASE1 |
| NCT04636918 | Singapore Eye Research Institute | Leukemia (Both ALL and AML)|MDS-EB-1 | 2019-11-28 | PHASE4 |
| NCT07565441 | Jemincare|Zhejiang Hangyu Pharmaceutical Co., Ltd. | ADPKD (Autosomal Dominant Polycystic Kidney Disease) | 2026-05-11 | PHASE1 |
| NCT00006056 | Fairview University Medical Center | Chediak-Higashi Syndrome|Graft Versus Host Disease|X-Linked Lymphoproliferative Syndrome|Familial Erythrophagocytic Lymphohistiocytosis|Hemophagocytic Lymphohistiocytosis|Virus-Associated Hemophagocytic Syndrome | 2000-03 | NA |
| NCT00630253 | Masonic Cancer Center, University of Minnesota | Fanconi Anemia | 2000-02-17 | PHASE1|PHASE2 |
| NCT00086346 | Wyeth is now a wholly owned subsidiary of Pfizer | Liver Transplantation | 2002-12 | PHASE3 |
| NCT00928018 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Massachusetts General Hospital|National Cancer Institute (NCI) | Non-hodgkin Lymphoma|Hodgkin Lymphoma | 2009-06 | PHASE3 |
| NCT00404482 | St. Franziskus Hospital | Uveitis|Juvenile Idiopathic Arthritis | 1991-01 | |
| NCT00369382 | Wyeth is now a wholly owned subsidiary of Pfizer | Graft Rejection|Kidney Failure | 2006-09 | PHASE4 |
| NCT00300274 | Novartis Pharmaceuticals | Graft Rejection | 2006-01 | PHASE3 |
| NCT00919503 | Fred Hutchinson Cancer Center|medac GmbH|National Cancer Institute (NCI)|National Heart, Lung, and Blood Institute (NHLBI) | Non-Neoplastic Hematologic and Lymphocytic Disorder | 2009-07-31 | PHASE2 |
| NCT00005941 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Cervical Cancer|Vaginal Cancer | 1999-11 | PHASE2 |
| NCT00740467 | Institut Paoli-Calmettes | Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Precancerous Condition | 2008-01 | PHASE2 |
| NCT01252667 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Acute Myeloid Leukemia | 2011-01-25 | PHASE2 |
| NCT00002831 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Leukemia | 1995-08-01 | PHASE1|PHASE2 |
| NCT01758107 | Chulalongkorn University | Renal Transplant | 2010-08 | PHASE4 |
| NCT00334672 | Children´s Cancer and Leukaemia Group | Nonneoplastic Condition | 2006-03 | PHASE3 |
| NCT00991458 | Allergan | Laser In Situ Keratomileusis | 2009-10 | PHASE2 |
| NCT00389870 | University of Leeds | Colorectal Cancer | 2006-12 | PHASE3 |
| NCT00796068 | Fred Hutchinson Cancer Center | Acute Biphenotypic Leukemia|Acute Lymphoblastic Leukemia in Remission|Acute Myeloid Leukemia in Remission|Blasts Under 5 Percent of Bone Marrow Nucleated Cells|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Myelodysplastic Syndrome (MDS) | 2009-02-24 | PHASE2 |
| NCT00228020 | Novartis | Pediatric Kidney Transplantation | 2001-05 | PHASE3 |
| NCT00003661 | Roswell Park Cancer Institute | Graft Versus Host Disease|Leukemia|Lymphoma|Myelodysplastic Syndromes|Neuroblastoma | 1998-06 | PHASE2 |
| NCT00908180 | Cancer Research UK | Lymphoma | 2009-07 | PHASE2 |
| NCT04877288 | Bristol-Myers Squibb | Renal Allograft Recipients | 2021-07-21 | PHASE3 |
| NCT00426023 | Campus Bio-Medico University|University of Genova|University of Padova | Vernal Keratoconjunctivitis | 2007-02 | PHASE3 |
| NCT00050648 | Rockefeller University|Facet Biotech | Psoriasis | 1997-10 | PHASE1|PHASE2 |
| NCT00093743 | Fred Hutchinson Cancer Center|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI) | Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Childhood Acute Myeloid Leukemia in Remission|Childhood Myelodysplastic Syndromes|Fanconi Anemia|Previously Treated Myelodysplastic Syndromes | 2000-01 | PHASE1 |
| NCT07368595 | Baylor College of Medicine|Harrow Inc | Dry Eye Disease (DED) | 2026-04-01 | PHASE4 |
| NCT04795752 | Sight Sciences, Inc. | Dry Eye|Meibomian Gland Dysfunction | 2021-04-28 | NA |
| NCT06147375 | Wei Gao | Immune Tolerance|Immunosuppression|Liver Transplant; Complications | 2023-12-01 | NA |
| NCT00006251 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Acute Undifferentiated Leukemia|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Childhood Burkitt Lymphoma|Childhood Diffuse Large Cell Lymphoma|Childhood Grade III Lymphomatoid Granulomatosis|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Chronic Myelomonocytic Leukemia|Cutaneous B-cell Non-Hodgkin Lymphoma|de Novo Myelodysplastic Syndromes|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Juvenile Myelomonocytic Leukemia|Mast Cell Leukemia|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Myeloid+NK-cell Acute Leukemia|Nodal Marginal Zone B-cell Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Post-transplant Lymphoproliferative Disorder|Previously Treated Myelodysplastic Syndromes|Primary Systemic Amyloidosis|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Renal Cell Cancer|Recurrent Small Lymphocytic Lymphoma|Recurrent+Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage II Multiple Myeloma|Stage III Multiple Myeloma|T-cell Large Granular Lymphocyte Leukemia|Testicular Lymphoma|Waldenstr?m Macroglobulinemia | 2000-05 | PHASE1|PHASE2 |
| NCT01342887 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Recurrent Adult Acute Myeloid Leukemia | 2011-04 | PHASE1|PHASE2 |
| NCT05245604 | Taejoon Pharmaceutical Co., Ltd. | Dry Eye Syndrome | 2020-06-19 | PHASE3 |
| NCT00119366 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Childhood Myelodysplastic Syndromes|Chronic Myelomonocytic Leukemia|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Refractory Anemia With Excess Blasts|Refractory Anemia With Excess Blasts in Transformation|Refractory Anemia With Ringed Sideroblasts|Refractory Cytopenia With Multilineage Dysplasia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes | 2003-05 | PHASE2 |
| NCT00002790 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Graft Versus Host Disease|Leukemia|Myelodysplastic Syndromes | 1996-03 | PHASE1|PHASE2 |
| NCT03791827 | Xiqiang Dang|The Children´s Hospital Affiliated to Suzhou University|Shandong Provincial Hospital|Guizhou Provincial People´s Hospital|LanZhou University|The First Affiliated Hospital of Inner Mongolia Medical College|People´s Hospital of Zhangjiajie|Puyang Oilfield General Hospital|The First Affiliated Hospital of Anhui Medical University|Guizhou Maternal and Child Health Care Hospital|Second Affiliated Hospital of Wenzhou Medical University|Shenzhen Children´s Hospital|The Second Affiliated Hospital of Harbin Medical University|Yichang Central People´s Hospital|Xian Children´s Hospital|Union Hospital, Tongji Medical College, Huazhong University of Science and Technology|The First People´s Hospital of Yunnan|The First Affiliated Hospital of Xiamen University|The First Affiliated Hospital of Xinxiang Medical College|Shanxi Provincial Maternity and Children´s Hospital|Liaocheng People´s Hospital|Fujian Provincial Hospital|First Affiliated Hospital of Guangxi Medical University|Lanzhou University Second Hospital|Guangzhou First People´s Hospital|The Second Hospital of Shandong University|Children´s Hospital of Hebei Province|Beijing Children´s Hospital|Zhengzhou Children´s Hospital|Children´s Hospital of Chongqing Medical University|Wuxi Women´s & Children´s Hospital|The Children´s Hospital of Fudan University|Shanghai Children´s Medical Center|Qilu Children´s Hospital of Shandong University | Lupus Nephritis|Children|Steroid|Immunosuppressive Treatment | 2018-12-01 | |
| NCT00068523 | Case Comprehensive Cancer Center | Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 2003-06 | NA |
| NCT01526850 | Chinese Academy of Medical Sciences|Zhejiang University|Chinese PLA General Hospital|307 Hospital of PLA|Peking Union Medical College | Chronic Graft Versus Host Disease | 2012-02 | PHASE2|PHASE3 |
| NCT02226068 | University of Aarhus | Atopic Dermatitis | 2002-06 | NA |
| NCT00348335 | Ophthalmic Consultants of Long Island|Allergan | Rosacea | 2006-06 | PHASE4 |
| NCT00775632 | University Health Network, Toronto|Bayer | Graft Versus Host Disease|Bone Marrow Transplantation | 2008-10 | PHASE2 |
| NCT00016419 | SWOG Cancer Research Network|National Cancer Institute (NCI) | Leukemia|Myelodysplastic Syndromes | 2001-08 | PHASE2 |
| NCT02435901 | Northwell Health | Sickle Cell Disease|Beta Thalassemia-Major | 2008-12 | PHASE1|PHASE2 |
| NCT03768609 | Janssen-Cilag International NV | Healthy | 2018-12-06 | PHASE1 |
| NCT07138898 | NYU Langone Health | Rheumatic Disease | 2025-09 | PHASE2 |
| NCT07558434 | Peking Union Medical College Hospital | Severe Aplastic Anemia (SAA)|Transfusion-dependent Non-severe Aplastic Anemia | 2026-04 | PHASE2 |
| NCT01552629 | Novartis Pharmaceuticals | Atopic Dermatitis | 2012-01-05 | PHASE2 |
| NCT00349583 | Innovative Medical | Cataract|Dry Eye | | PHASE4 |
| NCT00719888 | Fred Hutchinson Cancer Center | Acute Biphenotypic Leukemia|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Burkitt Lymphoma|Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Follicular Lymphoma|Lymphoblastic Lymphoma|Lymphoplasmacytic Lymphoma|Mantle Cell Lymphoma|Marginal Zone Lymphoma|Myelodysplastic Syndrome|Myelofibrosis|Non-Hodgkin Lymphoma|Plasma Cell Myeloma|Prolymphocytic Leukemia|Refractory Anemia|Small Lymphocytic Lymphoma | 2005-11-18 | PHASE2 |
| NCT04328727 | Novartis Pharmaceuticals | Severe Aplastic Anemia (SAA) | 2020-11-04 | PHASE2 |
| NCT00009776 | University of California, Davis | Lymphoma | 2001-03 | PHASE1 |
| NCT06824844 | Peking University Third Hospital | Dry Eye | 2021-12-02 | PHASE4 |
| NCT00257387 | Wyeth is now a wholly owned subsidiary of Pfizer | Kidney Transplant | 2004-06 | PHASE1|PHASE2 |
| NCT07345000 | Qilu Pharmaceutical Co., Ltd. | Treatment-na?ve Severe Aplastic Anemia | 2026-01 | PHASE3 |
| NCT00143806 | University of Medicine and Dentistry of New Jersey|Biogen | Psoriasis | 2003-10 | PHASE2 |
| NCT05057468 | Assiut University | Primary Autoimmune Hemolytic Anemia | 2021-10-20 | PHASE3 |
| NCT02176733 | University Hospital, Angers | Leber Hereditary Optic Neuropathy | 2011-07 | PHASE2 |
| NCT00004485 | Fred Hutchinson Cancer Center | Sickle Cell Anemia | 1999-12 | PHASE1|PHASE2 |
| NCT00003196 | Fred Hutchinson Cancer Center|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI) | Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage II Multiple Myeloma|Stage III Multiple Myeloma|Testicular Lymphoma|Waldenstr?m Macroglobulinemia | 1997-09 | NA |
| NCT00862979 | Novartis Pharmaceuticals | Heart Transplantation | 2009-02-24 | PHASE4 |
| NCT02653196 | Montefiore Medical Center|Children´s Hospital Los Angeles|Nationwide Children´s Hospital | Neuroepithelial Tumor|Solid Tumor|Allogeneic Hematopoietic Stem Cell Transplantation | 2015-09 | EARLY_PHASE1 |
| NCT00375895 | Rennes University Hospital|Novartis | Chronic Hepatitis C|Evidence of Liver Transplantation | 2006-06 | PHASE3 |
| NCT01968057 | Eli Lilly and Company | Healthy Volunteers | 2013-10 | PHASE1 |
| NCT05797623 | Jiangsu HengRui Medicine Co., Ltd. | Non-severe Aplastic Anemia | 2023-04-26 | PHASE2 |
| NCT00919542 | London School of Hygiene and Tropical Medicine|Homes and Hospitals of St Giles|Alert Hospital, Ethiopia|Armauer Hansen Research Institute, Ethiopia | Leprosy | 2010-07 | PHASE2 |
| NCT03466567 | Novo Nordisk A+S | Diabetes|Diabetes Mellitus, Type 2 | 2018-03-15 | PHASE1 |
| NCT00232063 | Novartis Pharmaceuticals | Severe Atopic Dermatitis | 2004-05 | PHASE3 |
| NCT00578370 | ISDIN | Psoriasis | 2007-11 | PHASE1|PHASE2 |
| NCT06898853 | The University of New South Wales|University of Melbourne | Dry Eye Disease (DED) | 2025-06-01 | NA |
| NCT00408187 | Aurinia Pharmaceuticals Inc. | Psoriasis | 2006-12 | PHASE3 |
| NCT02366585 | PerioC Limited | Periodontitis | 2015-03 | PHASE2 |
| NCT00182559 | Medical University of Vienna | End Stage Renal Disease | 2004-04 | PHASE4 |
| NCT00809172 | Hospices Civils de Lyon | Atopic Dermatitis | 2008-12 | PHASE3 |
| NCT00160966 | University of Giessen|Heidelberg University|Hoffmann-La Roche|Astellas Pharma Inc|Novartis | Polyomavirus Infections | 2004-09 | PHASE4 |
| NCT04237987 | Peking University People´s Hospital | Inflammatory Myopathy | 2020-01-21 | PHASE2 |
| NCT02280421 | Maruho Europe Limited | Healthy | 2014-10 | PHASE1 |
| NCT07169695 | Laboratoires Thea | Moderate to Severe Vernal Keratoconjunctivitis | 2026-03-24 | PHASE2 |
| NCT05839314 | Chinese PLA General Hospital|LinkDoc Technology (Beijing) Co. Ltd.|Huazhong University of Science and Technology | Nephropathy|Glomerular Diseases|Idiopathic Membranous Nephropathy | 2023-05-09 | PHASE4 |
| NCT02390674 | Newcastle-upon-Tyne Hospitals NHS Trust|National Institute for Health Research, United Kingdom|Newcastle University | Myocardial Reperfusion Injury | 2015-03 | PHASE2 |
| NCT05155007 | Janssen Research & Development, LLC | Healthy | 2021-12-10 | PHASE1 |
| NCT01231854 | Technische Universit?t Dresden | Atopic Dermatitis | 2010-11 | PHASE4 |
| NCT02397213 | Region Skane|NeuroVive Pharmaceutical AB | Acute Kidney Injury | 2015-04 | PHASE2 |
| NCT04424862 | Beijing Friendship Hospital | Efficacy | 2020-06-09 | PHASE4 |
| NCT00232076 | Novartis Pharmaceuticals | Severe Atopic Dermatitis | 2004-05 | PHASE3 |
| NCT00919815 | London School of Hygiene and Tropical Medicine|Homes and Hospitals of St Giles|Alert Hospital, Ethiopia|Armauer Hansen Research Institute, Ethiopia | Leprosy | 2010-08 | PHASE2|PHASE3 |
| NCT03382301 | Hospices Civils de Lyon | Renal Artery Stenosis | 2018-08-28 | PHASE2 |
| NCT05049668 | European Society for Blood and Marrow Transplantation | Severe Aplastic Anemia | 2021-10 | |
| NCT00057954 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) | Lymphoma | 2005-11-09 | PHASE2 |
| NCT03231592 | Community Health Center of Franklin County|Just Roots|Massachusetts General Hospital | Overweight and Obesity|Nutrition Poor|Diet Modification | 2017-05-10 | NA |
| NCT06944132 | Benha University | Pterygium|Pterygium of the Conjunctiva and Cornea | 2024-04-01 | NA |
| NCT01706471 | Yonsei University | Planned Kidney Transplantation | 2009-06 | PHASE4 |
| NCT05381766 | NYU Langone Health|National Institute on Minority Health and Health Disparities (NIMHD) | Diet Habit | 2023-06-07 | NA |
| NCT07375654 | Cairo University | Psoriasis | 2024-12-19 | PHASE1 |
| NCT03277040 | University of Pennsylvania | Diet Habit|Obesity|Food Habits | 2017-09-26 | NA |
| NCT02404025 | Novartis Pharmaceuticals | Aplastic Anemia | 2015-05-12 | PHASE2 |
| NCT07381556 | Erasmus Medical Center | Alopecia Areata(AA)|Alopecia Areata (AA)|Alopecia Totalis+Universalis|Alopecia Universalis (AU)|Alopecia Totalis (AT)|Alopecia Areata (& Ophiasis) | 2025-11-01 | PHASE4 |
| NCT04637633 | Farwaniya Hospital | Epiphora | 2020-08-15 | PHASE2|PHASE3 |
| NCT02870322 | University of Wisconsin, Madison|National Institutes of Health (NIH)|National Center for Complementary and Integrative Health (NCCIH) | Overweight|Obesity | 2016-07 | NA |